Ann H. Cory

2.9k citations

35 papers · 2.5k indexed · 1 hit paper · h-index 14

Co-authors: Joseph G. Cory Terence C. Owen J. A. Barltrop Alan C. Sartorelli Rick A. Finch Germana Rappa Aurelio Lorico John W. Sibert
Topics: Cancer-related Molecular Pathways (10 papers)Metal complexes synthesis and properties (7 papers)DNA Repair Mechanisms (6 papers)
Cited by: Oncology Toxicology Molecular Biology
Journals: Journal of Biological Chemistry Chemical Communications Biochemical and Biophysical Research Communications
Partner nations: United States

In The Last Decade

Ann H. Cory

35 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in Culture

1991 1.3k citations Ann H. Cory, Terence C. Owen et al. PubMed profile →

Peers

Countries citing papers authored by Ann H. Cory

Since Specialization

Citations

This map shows the geographic impact of Ann H. Cory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann H. Cory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann H. Cory more than expected).

Fields of papers citing papers by Ann H. Cory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann H. Cory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann H. Cory. The network helps show where Ann H. Cory may publish in the future.

Co-authorship network of co-authors of Ann H. Cory

This figure shows the co-authorship network connecting the top 25 collaborators of Ann H. Cory. A scholar is included among the top collaborators of Ann H. Cory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann H. Cory. Ann H. Cory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Understanding interactions between and among apoptosis inducing pathways in tumor cells. 2007 ·PubMed ·Ann H. Cory,Joseph G. Cory	2
2	Bis(2-hydroxybenzylidene)acetone, a potent inducer of the phase 2 response, causes apoptosis in mouse leukemia cells through a p53-independent, caspase-mediated pathway 2006 ·Cancer Letters ·Albena T. Dinkova‐Kostova,Ann H. Cory,Richard E. Bozak,Ronald J. Hicks,Joseph G. Cory	19
3	Induction of apoptosis in p53-deficient L1210 cells by an I-κ-B-α-inhibitor (Bay 11-7085) via a NF-κ-B-independent mechanism 2005 ·Advances in Enzyme Regulation ·Ann H. Cory,Joseph G. Cory	3
4	Gemcitabine-induced apoptosis in a drug-resistant mouse leukemia L1210 cell line that does not express p53 2004 ·Advances in Enzyme Regulation ·Ann H. Cory,Joseph G. Cory	3
5	Lipophilic derivatives of cyclam as new inhibitors of tumor cell growth 2002 ·Chemical Communications ·John W. Sibert,Ann H. Cory,Joseph G. Cory	53
6	Augmentation of apoptosis responses in p53-deficient L1210 cells by compounds directed at blocking NFkappaB activation. 2002 ·PubMed ·Ann H. Cory,Joseph G. Cory	12
7	Phenotypic changes in mouse leukemia L1210 cells with alterations in the effector-binding subunit of ribonucleotide reductase 2000 ·Advances in Enzyme Regulation ·Joseph G. Cory,(unknown),(unknown),Ann H. Cory	2
8	Lack of competition of substrates for P-glycoprotein in MCF-7 breast cancer cells overexpressing MDR1 1999 ·Advances in Enzyme Regulation ·Jennifer G. Hall,Ann H. Cory,Joseph G. Cory	7
9	Cellular Responses in Mouse Leukemia L1210 Cells Made Resistant to Deoxyadenosine 1998 ·Biochemical and Biophysical Research Communications ·Ann H. Cory,(unknown)	2
10	Multifactorial mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agents 1998 ·Advances in Enzyme Regulation ·Ann H. Cory,(unknown),(unknown)	7
11	Altered efflux properties of mouse leukemia L1210 cells resistant to 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone. 1998 ·PubMed ·Joseph G. Cory,Ann H. Cory,Aurelio Lorico,Germana Rappa,Alan C. Sartorelli	12
12	Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase 1997 ·Biochemical Pharmacology ·Germana Rappa,Aurelio Lorico,Mao‐Chin Liu,Gary D. Kruh,Ann H. Cory,Joseph G. Cory,Alan C. Sartorelli	30
13	Structure-function relationships for a new series of pyridine-2-carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivo 1995 ·Advances in Enzyme Regulation ·Joseph G. Cory,Ann H. Cory,Germana Rappa,Aurelio Lorico,(unknown),Tai‐Shun Lin,Alan C. Sartorelli	33
14	2′-deoxy-2′-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture 1994 ·Biochemical Pharmacology ·Ann H. Cory,Vicente Sámano,Morris J. Robins,Joseph G. Cory	17
15	Use of nucleoside kinase-deficient mouse leukemia L1210 cell lines to determine metabolic routes of activation of antitumor nucleoside analogs 1994 ·Advances in Enzyme Regulation ·Ann H. Cory,Joseph G. Cory	1
16	Inhibitors of ribonucleotide reductase 1994 ·Biochemical Pharmacology ·Joseph G. Cory,Ann H. Cory,Germana Rappa,Aurelio Lorico,(unknown),Tai‐Shun Lin,Alan C. Sartorelli	97
17	Structural aspects of N-hydroxy-N′-aminoguanidine derivatives as inhibitors of L1210 cell growth and ribonucleotide reductase activity 1993 ·Advances in Enzyme Regulation ·Joseph G. Cory,Ann H. Cory,(unknown),Anantha Narayanan,Stewart W. Schneller	5
18	Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in Culturebreakdown → 1991 ·PubMed ·Ann H. Cory,Terence C. Owen,J. A. Barltrop,Joseph G. Cory	1283
19	5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicators 1991 ·Bioorganic & Medicinal Chemistry Letters ·J. A. Barltrop,Terence C. Owen,Ann H. Cory,Joseph G. Cory	383
20	Liver microsomal inactivation of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone as an inhibitor of ribonucleotide reductase. 1988 ·PubMed ·(unknown),L Simonet,Ann H. Cory,Joseph G. Cory	2

About Ann H. Cory

Ann H. Cory is a scholar working on Oncology, Molecular Biology and Infectious Diseases, having authored 35 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Metal complexes synthesis and properties (7 papers) and DNA Repair Mechanisms (6 papers). The work is most often cited by research in Oncology (609 citations), Toxicology (66 citations) and Molecular Biology (1.1k citations). Ann H. Cory has collaborated with scholars based in United States. Frequent co-authors include Joseph G. Cory, Terence C. Owen, J. A. Barltrop, Alan C. Sartorelli, Rick A. Finch, Germana Rappa, Aurelio Lorico, John W. Sibert, Tai‐Shun Lin and Mao‐Chin Liu. Their work appears in journals such as Journal of Biological Chemistry, Chemical Communications and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact